Sökning: WFRF:(Saeedi Maryam 1991 ) > Characteristics of ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04807naa a2200469 4500 | |
001 | oai:DiVA.org:oru-67317 | |
003 | SwePub | |
008 | 180619s2018 | |||||||||||000 ||eng| | |
009 | oai:DiVA.org:uu-358524 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-673172 URI |
024 | 7 | a https://doi.org/10.1186/s12884-018-1875-12 DOI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3585242 URI |
040 | a (SwePub)orud (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Saeedi, Maryam,d 1991-u Örebro University hospital, Örebro, Sweden,Orebro Univ, Orebro Univ Hosp, Orebro, Sweden4 aut0 (Swepub:oru)mmsi |
245 | 1 0 | a Characteristics of different risk factors and fasting plasma glucose for identifying GDM when using IADPSG criteria :b a cross-sectional study |
264 | c 2018-06-13 | |
264 | 1 | b BioMed Central (BMC),c 2018 |
338 | a print2 rdacarrier | |
500 | a Funding Agency:Research committee of Örebro County | |
520 | a BACKGROUND: The Swedish National Board of Health and Welfare (SNBHW) recommended the new diagnostic criteria for GDM based upon Hyperglycaemia and Adverse Pregnancy Outcomes (HAPO) study thresholds. Due to limited knowledge base, no recommendations were made on GDM screening. The aim of this study is to evaluate test characteristics of risk factors and fasting blood glucose as screening tests for diagnosing GDM using diagnostic thresholds based upon HAPO study 1.75/2.0 (model I/II respectively) odds ratio for adverse pregnancy outcomes.METHODS: This cross-sectional, population-based study included all pregnant women who attended maternal health care in Örebro County, Sweden between the years 1994-96. A 75 g OGTT with capillary fasting and 2-h blood glucose was offered to all pregnant women at week 28-32. Risk factors and repeated random glucose samples were collected. Sensitivity, specificity and predictive values of blood glucose were calculated.RESULTS: Prevalence of GDM was 11.7% with model I and 7.2% with the model II criteria. Risk factors showed 28%, (95% CI 24-32) and 31%, (95% CI 25-37) sensitivity for model I and II respectively. A fasting cut off ≥4.8 mmol/l occurred in 24% of women with 91%, (95% CI 88-94) sensitivity and 85%, (95% CI 83-86) specificity using model I while a fasting cut off ≥5.0 mmol/l occurred in 14% with 91%, (95% CI 87-94) sensitivity and 92%, (95% CI 91-93) specificity using model II.CONCLUSION: Risk factor screening for GDM was found to be poorly predictive of GDM but fasting glucose of 4.8-5.0 mmol/l showed good test characteristics irrespective of diagnostic model and results in a low rate of OGTTs. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reproduktionsmedicin och gynekologi0 (SwePub)302202 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Obstetrics, Gynaecology and Reproductive Medicine0 (SwePub)302202 hsv//eng |
653 | a Gestational diabetes mellitus | |
653 | a Screening | |
653 | a Fasting plasma glucose | |
653 | a Risk factors | |
653 | a Sensitivity | |
700 | 1 | a Hanson, Ulf,d 1944-u Uppsala universitet,Obstetrisk och reproduktiv hälsoforskning,Orebro Univ Hosp, Sch Med Hlth & Sci, Dept Obstet & Gynecol, Orebro, Sweden4 aut0 (Swepub:uu)ulhan226 |
700 | 1 | a Simmons, David,d 1959-u Örebro universitet,Institutionen för medicinska vetenskaper,Department of Obstetrics and Gynecology, School of medical health and sciences, Örebro University Hospital, Örebro, Sweden; Macarthur Clinical School, Western Sydney University, Campbelltown, Australia,Orebro Univ Hosp, Sch Med Hlth & Sci, Dept Obstet & Gynecol, Orebro, Sweden;Western Sydney Univ, Macarthur Clin Sch, Campbelltown, NSW, Australia4 aut0 (Swepub:oru)dss |
700 | 1 | a Fadl, Helena,d 1965-u Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,Department of Obstetrics and Gynecology,Orebro Univ Hosp, Sch Med Hlth & Sci, Dept Obstet & Gynecol, Orebro, Sweden4 aut0 (Swepub:oru)hfl |
710 | 2 | a Örebro University hospital, Örebro, Swedenb Orebro Univ, Orebro Univ Hosp, Orebro, Sweden4 org |
773 | 0 | t BMC Pregnancy and Childbirthd : BioMed Central (BMC)g 18:1q 18:1x 1471-2393x 1471-2393 |
856 | 4 | u https://doi.org/10.1186/s12884-018-1875-1y Fulltext |
856 | 4 | u https://bmcpregnancychildbirth.biomedcentral.com/track/pdf/10.1186/s12884-018-1875-1.pdf |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:1244817/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-67317 |
856 | 4 8 | u https://doi.org/10.1186/s12884-018-1875-1 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-358524 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy